OpenAlex
PricingAboutJobs
Log inGet started
Work

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

HTML

Year: 2010
Type: article
Source: American Heart Journal
DOI: 10.1016/j.ahj.2009.07.035
Authors: Renato D. Lopes, John H. Alexander, Sana M. Al-Khatib, Jack Ansell, Raphael Diaz, J. Donald Easton, Bernard J. Gersh, Christopher B. Granger, Michael Hanna, John Horowitz, Elaine M. Hylek, John J.V. McMurray, Freek W.A. Verheugt, Lars Wallentin
Institutions: Duke Medical Center, Duke Clinical Research Institute, Lenox Hill Hospital, Brown University, Rhode Island Hospital, Mayo Clinic, Bristol-Myers Squibb (United States), The University of Adelaide, Boston University, Boston Medical Center, Western Infirmary, Uppsala University
Language: English

Topic: Atrial Fibrillation Management and Outcomes
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: apixaban, warfarin, atrial fibrillation, stroke prevention, systemic embolism, factor Xa inhibitors, vitamin K antagonists, non-inferiority, hemorrhage, all-cause mortality, ARISTOTLE trial
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2118857793
FWCI: 40.46
Cites: 34
Cited by: 489
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms